Last year marked the eighth year of enforcement of China’s Anti-Monopoly Law. As discussed below, the year was notable on a number of fronts.
China’s merger control authority, MOFCOM,...
Yesterday, the Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds under which transactions will be reportable only if, as a result of such t...
The Anti-Monopoly Commission (“AMC”) has charged four Chinese state agencies with developing guidelines on when IPR-related conduct violates China’s Anti-Monopoly Law. So far, two o...
On October 20, 2016, the Federal Trade Commission (“FTC”) and Department of Justice: Antitrust Division (“DOJ”) jointly issued antitrust law guidance for human resource profession...
In a closely watched case that has been pending in the federal courts for over a decade—a series of private lawsuits alleging that Chinese manufacturers had colluded to fix prices of vi...
On June 29, 2016, the Federal Trade Commission (“FTC”) announced an increase in the maximum civil penalties it may impose for violations of the Hart-Scott-Rodino Act (“HSR Act”) a...
Articles & Books
The International Comparative Legal Guide to: Lending & Secured Finance 2016
A team of attorneys from Davis Polk & Wardwell LLP presented the ABA’s January Antitrust Update for In-House Counsel. The following article summarizes one of the recent developments dis...
Articles & Books
Antitrust, vol. 28, no. 1, Fall 2013, American Bar Association
THIS PAST SPRING, A NEW YORK JURY found Chinese manufacturers of vitamin C liable for fixing prices of exports from China into the United States, in violation of U.S. antitrust laws. In t...
After more than a decade of litigation in the lower courts, the Supreme Court yesterday heard oral argument in a case of considerable consequence to the pharmaceutical industry. The issue...
Looking back at 2012, four years after China implemented its Anti-Monopoly Law (“AML”), we can discern some important ways in which China’s antitrust regime today both mirrors and d...
